Market Access
Developing a Data Acquisition Strategy for Your Specialty Brand
Information collection for tracking specialty product distribution in the U.S. has become highly fragmented, ...
Return on Reputation: How A Better Rep Can Lead to More Success
Earlier this month, APCO Worldwide released its findings from its third annual State of ...
How the Affordable Care Act Changes the Patient Journey (Part Two)
Evidence-Based Medicine Along with creating an increase in healthcare demand and the subsequent provider ...
Six Factors You Shouldn’t Ignore When Marketing Your Brand to Payers
No matter how strong the portfolio, every pharmaceutical company has at least one product ...
A Pharma Marketer’s Guide to Multivariate Analyses
Putt’s Law states, “Technology is dominated by two types of people: Those who understand ...
When It Comes to Licensing Deals, It’s All About Market Access
Reduced internal R&D productivity, patent expirations and stagnant global economic growth have caused pharma ...
- 2013
- Digital Tactics
- Feature Articles
- Industry News
- Issues
- July
- Market Access
- Slideshow
- Social Media
- Uncategorized
Decision-Makers and a Dynamic Marketplace: Who and What Are Leading Today’s Marketing Power Shift?
The quest to understand drivers of product uptake and use is as old as ...
The Bellwethers of Brand Performance
As is often the case, it’s not a single driver that shapes a trend ...
What Does An “Orphan Drug” Designation Mean?
In the 1990s, a visionary named Bill Aliski sparked an interest in rare diseases ...
How the Affordable Care Act Changes the Patient Journey (Part One)
Whether you supported it or opposed it, as 2013 unfolds “Obama Care”/ “The Affordable ...
U.S. Drug Market Trends: Looking Beyond the LOE to the New Normal
The IMS Institute for Healthcare Informatics released important findings recently in their report Declining ...
How to Properly Evaluate Creative
Art is subjective. Two people can view the same image or read the same ...
